stronger than tirzepatide A 72-week trial compared the two leading GLP-1 medications in adults with obesity (no diabetes). The results: ✓ Tirzepatide: 20.2% weight loss ✓ Semaglutide: 13.7% weight loss But weight loss isn't the TrimRX | Is Zepbound Stronger

Inconsistent dosing and treatment gaps Missing doses destroys consistency and limits results

There has been a large phase 3 clinical trial programme, SURMOUNT, undertaken in people who do not have diabetes

Glucagon-like Peptide-1 (GLP-1) Agonists

Tolerability Adverse effects are similar to those of other GLP-1 receptor agonists

If your provider gave you a chart without specifying concentration, there is a good chance it assumes 10 mg/mL

As of February 23, 2026, the manufacturer has a promotion for the Zepbound Self Pay Journey Program, which lowers rates to $449 for each 1-month supply of the 7.5 mg, 10 mg, 12.5 mg, and 15 mg Zepbound single-dose vial or Zepbound KwikPen for single-patient-use